ArticleCancer research2018

The CARMA3-Bcl10-MALT1 Signalosome Drives NFκB Activation and Promotes Aggressiveness in Angiotensin II Receptor-Positive Breast Cancer.

Prasanna Ekambaram et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.